Truqap is actually a kinase inhibitor that works by blocking pathways that aid the cancer cells survive and increase, so cuts down cancer progress. Truqap is from a class of medicines identified as an AKT inhibitor. Truqap been given FDA approval on November 17, 2023, right after beneficial success with https://joann898hte3.levitra-wiki.com/user